One in five cancer patients face the possibility of developing a blood clot. This serious condition is a leading cause of death among individuals with cancer.
Our vascular medicine team has specific expertise in the treatment and prevention of cancer-associated thrombosis and works closely with Kellogg Cancer Center specialists in the care of patients most at risk. Contributing to advances in patient care through innovative research, NorthShore is currently participating in three clinical trials focused on the use of novel anticoagulants for treatment and prevention of cancer-associated thrombosis.
For More Information
To request additional information or schedule an appointment with one of our vascular medicine specialists, please call 847.663.8050.